ADARx Pharmaceuticals, Inc. (ADRX) vs Galecto, Inc. (DMRA)

ADARx Pharmaceuticals, Inc. ADRX 15.57 +17.07%
Galecto, Inc. DMRA 22.08 −5.03%

ADARx Pharmaceuticals, Inc. and Galecto, Inc. are both Biotechnology companies. ADARx Pharmaceuticals, Inc. and Galecto, Inc. are of similar size ($1.5B and $1.4B).

Metric	ADRX	DMRA	Biotechnology median
P/E	—	24.38	11.58
P/S	—	n/m	9.61
P/B	—	3.96	2.26
Price to free cash flow	—	n/m	26.41
EV/EBITDA	—	n/m	0.72
EV/Sales	—	n/m	9.43
Earnings yield	—	4.10%	(32.28%)
Free cash flow yield	—	(4.09%)	(22.27%)

Metric	ADRX	DMRA	Biotechnology median
Gross margin	—	0.00%	68.81%
Operating margin	—	0.00%	0.00%
Net margin	—	0.00%	0.00%
Free cash flow margin	—	0.00%	0.00%
Return on equity	—	(39.51%)	(50.30%)
Return on assets	—	(27.08%)	(45.47%)
Return on invested capital	—	0.00%	0.00%

Metric	ADRX	DMRA	Biotechnology median
Revenue growth (TTM)	—	—	6.78%
EPS growth (last fiscal year)	—	(730.84%)	29.88%
Revenue growth, 5-year CAGR	—	—	9.75%
Net income growth, 5-year CAGR	—	0.00%	0.00%

Metric	ADRX	DMRA	Biotechnology median
Debt to equity	—	0.00	0.00
Current ratio	—	14.80	4.74
Net debt to EBITDA	—	1.22	1.01

Metric	ADRX	DMRA	Biotechnology median
Dividend yield	—	—	0.39%
Payout ratio	—	—	—

Metric	ADRX	DMRA	Biotechnology median
Market cap	1.47b	1.44b	168.63m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack